What Should I Know Before Starting Argus II Implantations?
We hope everyone is having a wonderful holiday season. We had the opportunity to catch up with the Cole Eye Institute Argus II team, led by Aleksandra Rachitskaya, Meghan DeBenedictis,…
FDA Approves Luxturna Gene Replacement Therapy: Discussion with Rachel Huckfeldt and Jacque Duncun
Rachel Huckfeldt, MD, PhD Inherited Retinal Diseases Service Mass Eye and Ear / Harvard Medical School Earlier this week on Tuesday December 19th, the FDA announced its approval of Luxturna…
When Things Go South: The 30-year OMIC Experience in Retinal Malpractice presented by George A. Williams, M.D.
Karen Jeng-Miller, MD, MPH Ophthalmology Resident Mass Eye and Ear, Harvard Medical School Archana Seethala, MD Assistant Professor of Ophthalmology Vitreoretinal Surgery, Boston Medical Center The 767th New England Ophthalmological…
What’s New with Tie2
Eric Nudleman, MD, PhD Shiley Eye Institute, UCSD Editor, RETINA Roundup Although anti-VEGF therapy has revolutionized the management of retinal vascular diseases, there has been significant effort in recent years…
Coding Corner: ICD10 Update on Myopic Degeneration
Ankoor R. Shah, MD ASRS CPT Advisor to the AMA Retina Consultants of Houston October has come and gone which means the leaves have changed colors, a new World Series…
How to Keep your Cornea Colleagues Happy
Yoshihiro Yonekawa, MD Mass Eye and Ear / Boston Children’s Hospital Editor, RETINA Roundup We hope everyone is having an enjoyable Thanksgiving weekend! This is the first article of a…
AAO 2017 Retina Subspecialty Day: Innovative Retinal Interventions Session
Parisa E. Naeini, MD Vitreoretinal Surgery Fellow University of California, Davis In the “innovative retinal interventions” session, novel methods of treating retinal conditions were discussed. Dr. Kazuaki Kadonosono introduced cannulation…
AAO 2017 Retina Subspecialty Day: Protocol U
Kevin Chen, MD Vitreoretinal Surgery Fellow University of California San Diego Dr. Raj Maturi reported on data from the highly anticipated DRCR.net Protocol U. This study is a multicenter randomized…